UBS AM
EOLS icon

UBS AM’s Evolus EOLS Stock Holding History

UBS AM’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-112,966
Closed -$694K – 3297
2025
Q3 		$694K Sell
112,966
-62,593
-36% -$488K ﹤0.01% 2106
2025
Q2 		$1.62M Buy
175,559
+18,994
+12% +$194K ﹤0.01% 2234
2025
Q1 		$1.88M Buy
156,565
+41,513
+36% +$543K ﹤0.01% 2021
2024
Q4 		$1.27M Buy
115,052
+6,821
+6% +$95.9K ﹤0.01% 2266
2024
Q3 		$1.75M Sell
108,231
-8,301
-7% -$116K ﹤0.01% 2111
2024
Q2 		$1.26M Buy
116,532
+49,785
+75% +$612K ﹤0.01% 2253
2024
Q1 		$934K Hold
66,747
– – ﹤0.01% 2047
2023
Q4 		$703K Buy
66,747
+5,533
+9% +$49.5K ﹤0.01% 2205
2023
Q3 		$559K Hold
61,214
– – ﹤0.01% 2254
2023
Q2 		$518K Hold
61,214
– – ﹤0.01% 2307
2023
Q1 		$518K Buy
61,214
+5,553
+10% +$50.2K ﹤0.01% 2307
2022
Q4 		$418K Buy
55,661
+20,151
+57% +$156K ﹤0.01% 2243
2022
Q3 		$286K Sell
35,510
-8,139
-19% -$86.3K ﹤0.01% 2504
2022
Q2 		$506K Buy
+43,649
New +$515K ﹤0.01% 2309
2020
Q2 		– Sell
-23,200
Closed -$96.3K – 2484
2020
Q1 		$96.3K Sell
23,200
-1,509
-6% -$12.8K ﹤0.01% 2398
2019
Q4 		$301K Buy
24,709
+14,009
+131% +$198K ﹤0.01% 2368
2019
Q3 		$167K Hold
10,700
– – ﹤0.01% 2609
2019
Q2 		$156K Buy
+10,700
New +$212K ﹤0.01% 2593

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's EOLS Position: Q4 2025 in Review

UBS AM sold out of Evolus (EOLS) in Q4 2025, closing a stake of 112,966 shares — an estimated $694K sold.

UBS AM first reported a position in EOLS in Q2 2019 and held it in 18 quarters. The position peaked at $1.88M in Q1 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • UBS AM reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • UBS AM sold 112,966 Evolus shares in Q4 2025, an estimated $694K.
  • UBS AM first reported a position in Evolus in Q2 2019 and held it in 18 quarters.
  • UBS AM's Evolus position peaked at $1.88M in Q1 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.